# Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/cetuximab-plus-chemotherapy-in-patients-with-advanced-non-small-cell-lung-cancer/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Robert Pirker,Jose R. Pereira,Aleksandra Szczęsna,Joachim von Pawel,Maciej Krzakowski,Rodryg Ramlau,Ihor Vynnychenko,Keunchil Park,Chih-Teng Yu,Valentyn Ganul,Jae-Kyung Roh,Emilio Bajetta,Kenneth J. O’Byrne,Filippo de Marinis,Wilfried Eberhardt,Thomas Goddemeier,Michael Emig,U. Gatzemeier |
| Citations | 1,356 |
| DOI | 10.1016/s0140-6736(09)60569-9 |
| Fields | Medicine |
| Open Access | true |
| OA Status | green |
| OA URL | https://ir.ymlib.yonsei.ac.kr/handle/22282913/104868 |
| OpenAlex ID | https://openalex.org/W2168340462 |
| PMID | 19410716 |
| Type | article |
| Year | 2009 |

## Paper authors

- [Keunchil Park](https://scholariq.org/researchers/keunchil-park/)

## Paper journal

- [The Lancet](https://scholariq.org/journals/the-lancet/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.